News
September 12, 2019
ARC sponsored Satellite Symposium at HFSA
For the third year running, ARC is supporting a CME Satellite Symposium at the Heart Failure Society of America (HFSA) conference. “Avoiding the pitfalls of diagnosing and treating cardiac ATTR amyloidosis” will be held on Sunday evening, September 15, at 6:30 pm.
- Categories
- Lastest Posts
- Phase 3 Clinical Trial of Birtamimab in AL Amyloidosis Fails to Meet Primary Endpoint
- FDA Approves Amvuttra™ (vutrisiran) for ATTR-CM: More Options for Patients
- FDA Approves Attruby™ (acoramidis) for the Treatment of ATTR-CM: A New Option for Patients
- ARC Launches Clinical Fellowship Program to Advance Amyloidosis Care
